Molecular Mechanism of lncRNAs in Regulation of Breast Cancer Metastasis; a Comprehensive Review.
Breast cancer
Long non-coding RNAs
Metastasis
lncRNAs
miRNAs
Journal
Cell biochemistry and biophysics
ISSN: 1559-0283
Titre abrégé: Cell Biochem Biophys
Pays: United States
ID NLM: 9701934
Informations de publication
Date de publication:
05 Oct 2024
05 Oct 2024
Historique:
accepted:
07
09
2024
medline:
5
10
2024
pubmed:
5
10
2024
entrez:
4
10
2024
Statut:
aheadofprint
Résumé
Although the number of breast cancer deaths has decreased, and there have been developments in targeted therapies and combination treatments for the management of metastatic illness, metastatic breast cancer is still the second most common cause of cancer-related deaths in U.S. women. Numerous phases and a vast number of proteins and signaling molecules are involved in the invasion-metastasis cascade. The tumor cells penetrate and enter the blood or lymphatic vessels, and travel to distant organs via the lymphatic or blood vessels. Tumor cells enter cell cycle arrest, adhere to capillary beds in the target organ, and then disseminate throughout the organ's parenchyma, proliferating and enhancing angiogenesis. Each of these processes is regulated by changes in the expression of different genes, in which lncRNAs play a role in this regulation. Transcripts that are longer than 200 nucleotides and do not translate into proteins are called RNAs. LncRNA molecules, whose function depends on their unique molecular structure, play significant roles in controlling the expression of genes at various epigenetic levels, transcription, and so on. LncRNAs have essential functions in regulating the expression of genes linked to cell development in healthy and pathological processes, specialization, programmed cell death, cell division, invasion, DNA damage, and spread to other parts of the body. A number of cancer types have been shown to exhibit aberrant expression of lncRNAs. In this review, we describe the general characteristics, potential molecular mechanisms and targeted therapy of lncRNAs and discuss the emerging functions of lncRNAs in breast cancer.
Identifiants
pubmed: 39367197
doi: 10.1007/s12013-024-01535-y
pii: 10.1007/s12013-024-01535-y
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Plevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., Lee, S. J., van den Broek, J. J., Huang, X., Schechter, C. B., Sprague, B. L., Song, J., de Koning, H. J., Trentham-Dietz, A., van Ravesteyn, N. T., Gangnon, R., Chandler, Y., Li, Y., Xu, C., Ergun, M. A., Huang, H., Berry, D. A., & Mandelblatt, J. S. (2018). Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012. Jama, 319(2), 154–164.
doi: 10.1001/jama.2017.19130
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D., Feuer, E. J., & Cancer Intervention and Surveillance Modeling Network (CISNET) C. (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine, 353(17), 1784–1792.
doi: 10.1056/NEJMoa050518
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N. & Chen, W. (2022). Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chinese Medical Journal, 135(05), 584–590.
Majeed, W., Aslam, B., Javed, I., Khaliq, T., Muhammad, F., Ali, A., & Raza, A. (2014). Breast cancer: major risk factors and recent developments in treatment. Asian Pacific Journal of Cancer Prevention, 15(8), 3353–3358.
doi: 10.7314/APJCP.2014.15.8.3353
DeSantis, C. E., Fedewa, S. A., Goding Sauer, A., Kramer, J. L., Smith, R. A., & Jemal, A. (2016). Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA: A Cancer Journal for Clinicians, 66(1), 31–42.
Poste, G., & Fidler, I. J. (1980). The pathogenesis of cancer metastasis. Nature, 283(5743), 139–146.
doi: 10.1038/283139a0
Ha, N.-H., Faraji, F., & Hunter, K. W. (2013) Mechanisms of metastasis. Cancer Targeted Drug Delivery: An Elusive Dream, 435–458.
Talmadge, J. E., & Fidler, I. J. (2010). AACR centennial series: the biology of cancer metastasis: Historical perspective. Cancer Research, 70(14), 5649–5669.
doi: 10.1158/0008-5472.CAN-10-1040
Quinn, J. J., & Chang, H. Y. (2016). Unique features of long non-coding RNA biogenesis and function. Nature Reviews Genetics, 17(1), 47–62.
doi: 10.1038/nrg.2015.10
Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet-Meillon, F., Bonnet, I., Costa, A., Givel, A. M., Attieh, Y., Barbazan, J., Bonneau, C., Fuhrmann, L., Descroix, S., Vignjevic, D., Silberzan, P., Parrini, M. C., Vincent-Salomon, A., & Mechta-Grigoriou, F. (2020). Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nature Communications, 11(1), 404.
doi: 10.1038/s41467-019-14134-w
Weigelt, B., Peterse, J. L., & Van’t Veer, L. J. (2005). Breast cancer metastasis: markers and models. Nature Reviews Cancer, 5(8), 591–602.
doi: 10.1038/nrc1670
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G., Uhr, J. W., & Terstappen, L. W. (2004). Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research, 10(20), 6897–6904.
doi: 10.1158/1078-0432.CCR-04-0378
van de Stolpe, A., et al. (2011). Circulating tumor cell isolation and diagnostics: toward routine clinical use. AACR.
Sosnoski, D. M., Norgard, R. J., Grove, C. D., Foster, S. J., & Mastro, A. M. (2015). Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment. Clinical & Experimental Metastasis, 32, 335–344.
doi: 10.1007/s10585-015-9710-9
Quayle, L., Ottewell, P. D., & Holen, I. (2015). Bone metastasis: molecular mechanisms implicated in tumour cell dormancy in breast and prostate cancer. Current Cancer Drug Targets, 15(6), 469–480.
doi: 10.2174/1568009615666150506092443
Ij, F.(1978). The biology of cancer invasion and metastasis. Advanced Cancer Research, 28, 149–250.
doi: 10.1016/S0065-230X(08)60648-X
Paget, S. (1889). The distribution of secondary growths in cancer of the breast. The Lancet, 133(3421), 571–573.
doi: 10.1016/S0140-6736(00)49915-0
Psaila, B., Kaplan, R. N., Port, E. R., & Lyden, D. (2007). Priming the ‘soil’for breast cancer metastasis: the pre-metastatic niche. Breast Disease, 26(1), 65–74.
doi: 10.3233/BD-2007-26106
Minn, A. J., Kang, Y., Serganova, I., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R., & Massagué, J. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. The Journal of Clinical Investigation, 115(1), 44–55.
doi: 10.1172/JCI22320
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3(6), 537–549.
doi: 10.1016/S1535-6108(03)00132-6
Liu, Y., & Cao, X. (2016). Characteristics and significance of the pre-metastatic niche. Cancer Cell, 30(5), 668–681.
doi: 10.1016/j.ccell.2016.09.011
Thiery, J. P. (2002). Epithelial–mesenchymal transitions in tumour progression. Nature Reviews Cancer, 2(6), 442–454.
doi: 10.1038/nrc822
Guarino, M., Rubino, B., & Ballabio, G. (2007). The role of epithelial‐mesenchymal transition in cancer pathology. Pathology, 39(3), 305–318.
doi: 10.1080/00313020701329914
Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M., Thompson, E. W., Polette, M., & Gilles, C. (2010). Epithelial-to-mesenchymal transitions and circulating tumor cells. Journal of Mammary Gland Biology and Neoplasia, 15, 261–273.
doi: 10.1007/s10911-010-9174-0
Mego, M., Mani, S. A., & Cristofanilli, M. (2010). Molecular mechanisms of metastasis in breast cancer—clinical applications. Nature Reviews Clinical Oncology, 7(12), 693–701.
doi: 10.1038/nrclinonc.2010.171
McSherry, E. A., Donatello, S., Hopkins, A. M., & McDonnell, S. (2007). Molecular basis of invasion in breast cancer. Cellular and Molecular Life Sciences: CMLS, 64(24), 3201–3218.
doi: 10.1007/s00018-007-7388-0
Bell, C., & Waizbard, E. (1986). Variability of cell size in primary and metastatic human breast carcinoma. Invasion & Metastasis, 6(1), 11–20.
Yilmaz, M., & Christofori, G. (2010). Mechanisms of motility in metastasizing cells. Molecular Cancer Research, 8(5), 629–642.
doi: 10.1158/1541-7786.MCR-10-0139
Kalluri RZeisberg, M.(2006). Fibroblasts in cancer. Nature Reviews Cancer, 6, 392401
De Palma, M., Venneri, M. A., Roca, C., & Naldini, L. (2003). Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nature Medicine, 9(6), 789–795.
doi: 10.1038/nm871
Karamali, N., Daraei, A., Rostamlou, A., Mahdavi, R., Akbari Jonoush, Z., Ghadiri, N., Mahmoudi, Z., Mardi, A., Javidan, M., Sohrabi, S., & Baradaran, B. (2024). Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer. Cancer Cell International, 24(1), 104.
doi: 10.1186/s12935-024-03296-3
Fidler, I. J., Kim, S. J., & Langley, R. R. (2007). The role of the organ microenvironment in the biology and therapy of cancer metastasis. Journal of Cellular Biochemistry, 101(4), 927–936.
doi: 10.1002/jcb.21148
Psaila, B., & Lyden, D. (2009). The metastatic niche: adapting the foreign soil. Nature Reviews Cancer, 9(4), 285–293.
doi: 10.1038/nrc2621
Coghlin, C., & Murray, G. I. (2010). Current and emerging concepts in tumour metastasis. The Journal of Pathology, 222(1), 1–15.
doi: 10.1002/path.2727
Lorusso, G. & Rüegg, C. (2012). New insights into the mechanisms of organ-specific breast cancer metastasis. in Seminars in cancer biology. Elsevier
de Castro Junior, G., Puglisi, F., de Azambuja, E., El Saghir, N. S., & Awada, A. (2006). Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the “do ut des” paradigm). Critical Reviews in Oncology/Hematology, 59(1), 40–50.
doi: 10.1016/j.critrevonc.2006.02.007
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646–674.
doi: 10.1016/j.cell.2011.02.013
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70.
doi: 10.1016/S0092-8674(00)81683-9
Bergers, G., & Benjamin, L. E. (2003). Tumorigenesis and the angiogenic switch. Nature Reviews Cancer, 3(6), 401–410.
doi: 10.1038/nrc1093
Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249–257.
doi: 10.1038/35025220
Fan, F., Schimming, A., Jaeger, D. & Podar, K. (2012). Targeting the tumor microenvironment: focus on angiogenesis. Journal of Oncology, 281261.
Moghadam, R. K., Daraei, A., Haddadi, M., Mardi, A., Karamali, N., & Rezaiemanesh, A. (2024). Casting Light on the Janus-Faced HMG-CoA reductase degradation protein 1: a comprehensive review of its dualistic impact on apoptosis in various diseases. Molecular Neurobiology, 61, 1–22.
doi: 10.1007/s12035-024-03994-z
Jain, R. K. (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 307(5706), 58–62.
doi: 10.1126/science.1104819
de Oliveira, R. L., Hamm, A., & Mazzone, M. (2011). Growing tumor vessels: more than one way to skin a cat–implications for angiogenesis targeted cancer therapies. Molecular Aspects of Medicine, 32(2), 71–87.
doi: 10.1016/j.mam.2011.04.001
Harris, A. L. (2002). Hypoxia—a key regulatory factor in tumour growth. Nature Reviews Cancer, 2(1), 38–47.
doi: 10.1038/nrc704
Pugh, C. W., & Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine, 9(6), 677–684.
doi: 10.1038/nm0603-677
Luu, T., Chung, C., & Somlo, G. (2011). Combining emerging agents in advanced breast cancer. The Oncologist, 16(6), 760–771.
doi: 10.1634/theoncologist.2010-0345
Gunasinghe, N. P., Wells, A., Thompson, E. W., & Hugo, H. J. (2012). Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer and Metastasis Reviews, 31, 469–478.
doi: 10.1007/s10555-012-9377-5
Clark, M. B., Amaral, P. P., Schlesinger, F. J., Dinger, M. E., Taft, R. J., Rinn, J. L., Ponting, C. P., Stadler, P. F., Morris, K. V., Morillon, A., Rozowsky, J. S., Gerstein, M. B., Wahlestedt, C., Hayashizaki, Y., Carninci, P., Gingeras, T. R., & Mattick, J. S. (2011). The reality of pervasive transcription. PLoS Biology, 9(7), e1000625.
doi: 10.1371/journal.pbio.1000625
Hangauer, M. J., Vaughn, I. W., & McManus, M. T. (2013). Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genetics, 9(6), e1003569.
doi: 10.1371/journal.pgen.1003569
Yu, A. D., Wang, Z., & Morris, K. V. (2015). Long noncoding RNAs: a potent source of regulation in immunity and disease. Immunology and Cell Biology, 93(3), 277–283.
doi: 10.1038/icb.2015.2
Mehmandar-Oskuie, A., Jahankhani, K., Rostamlou, A., Mardafkan, N., Karamali, N., Razavi, Z. S., & Mardi, A. (2024). Molecular mechanism of lncRNAs in pathogenesis and diagnosis of auto-immune diseases, with a special focus on lncRNA-based therapeutic approaches. Life Sciences, 2023, 122322.
doi: 10.1016/j.lfs.2023.122322
Aune, T. M., Crooke, P. S., & Spurlock, C. F. (2016). Long noncoding RNAs in T lymphocytes. Journal of Leucocyte Biology, 99(1), 31–44.
doi: 10.1189/jlb.1RI0815-389R
Aune, T. M., & Spurlock, III, C. F. (2016). Long non-coding RNAs in innate and adaptive immunity. Virus Research, 212, 146–160.
doi: 10.1016/j.virusres.2015.07.003
van Heesch, S., van Iterson, M., Jacobi, J., Boymans, S., Essers, P. B., de Bruijn, E., Hao, W., MacInnes, A. W., Cuppen, E., & Simonis, M. (2014). Extensive localization of long noncoding RNAs to the cytosol and mono-and polyribosomal complexes. Genome Biology, 15, 1–12.
Cabili, M. N., Dunagin, M. C., McClanahan, P. D., Biaesch, A., Padovan-Merhar, O., Regev, A., Rinn, J. L., & Raj, A. (2015). Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biology, 16, 1–16.
doi: 10.1186/s13059-015-0586-4
Lin, M.-T., Song, H.-J., & Ding, X.-Y. (2018). Long non-coding RNAs involved in metastasis of gastric cancer. World Journal of Gastroenterology, 24(33), 3724–3737.
doi: 10.3748/wjg.v24.i33.3724
Liu, Y., Ding, W., Yu, W., Zhang, Y., Ao, X., & Wang, J. (2021). Long non-coding RNAs: biogenesis, functions, and clinical significance in gastric cancer. Molecular Therapy-Oncolytics, 23, 458–476.
doi: 10.1016/j.omto.2021.11.005
Mehmandar-Oskuie, A., Jahankhani, K., Rostamlou, A., Arabi, S., Sadat Razavi, Z., & Mardi, A. (2023). Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies. Biomedicine & Pharmacotherapy, 165, 115242.
doi: 10.1016/j.biopha.2023.115242
Sun, M., Nie, F., Wang, Y., Zhang, Z., Hou, J., He, D., Xie, M., Xu, L., De, W., Wang, Z., & Wang, J. (2016). LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Research, 76(21), 6299–6310.
doi: 10.1158/0008-5472.CAN-16-0356
Saeidi, N., Goudarzvand, H., Mohammadi, H., Mardi, A., Ghoreishizadeh, S., Shomali, N., & Goudarzvand, M. (2023). Dysregulation of miR-193a serves as a potential contributor to MS pathogenesis via affecting RhoA and Rock1. Multiple Sclerosis and Related Disorders, 69, 104468.
doi: 10.1016/j.msard.2022.104468
Wang, K. C., Yang, Y. W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y., Lajoie, B. R., Protacio, A., Flynn, R. A., Gupta, R. A., Wysocka, J., Lei, M., Dekker, J., Helms, J. A., & Chang, H. Y. (2011). A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature, 472(7341), 120–124.
doi: 10.1038/nature09819
Toki, N., Takahashi, H., Zucchelli, S., Gustincich, S., & Carninci, P. (2020). Synthetic in vitro transcribed lncRNAs (SINEUPs) with chemical modifications enhance target mRNA translation. FEBS Letters, 594(24), 4357–4369.
doi: 10.1002/1873-3468.13928
Zucchelli, S., Cotella, D., Takahashi, H., Carrieri, C., Cimatti, L., Fasolo, F., Jones, M. H., Sblattero, D., Sanges, R., Santoro, C., Persichetti, F., Carninci, P., & Gustincich, S. (2015). SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation. RNA Biology, 12(8), 771–779.
doi: 10.1080/15476286.2015.1060395
Carrieri, C., Cimatti, L., Biagioli, M., Beugnet, A., Zucchelli, S., Fedele, S., Pesce, E., Ferrer, I., Collavin, L., Santoro, C., Forrest, A. R., Carninci, P., Biffo, S., Stupka, E., & Gustincich, S. (2012). Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature, 491(7424), 454–457.
doi: 10.1038/nature11508
Toki, N., Takahashi, H., Sharma, H., Valentine, M., Rahman, F. M., Zucchelli, S., Gustincich, S., & Carninci, P. (2020). SINEUP long non-coding RNA acts via PTBP1 and HNRNPK to promote translational initiation assemblies. Nucleic Acids Research, 48(20), 11626–11644.
doi: 10.1093/nar/gkaa814
Indrieri, A., Grimaldi, C., Zucchelli, S., Tammaro, R., Gustincich, S., & Franco, B. (2016). Synthetic long non-coding RNAs [SINEUPs] rescue defective gene expression in vivo. Scientific Reports, 6(1), 27315.
doi: 10.1038/srep27315
Zhang, M., et al. (2017). lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT. European Review for Medical & Pharmacological Sciences, 21(5).
Li, Z., Hou, P., Fan, D., Dong, M., Ma, M., Li, H., Yao, R., Li, Y., Wang, G., Geng, P., Mihretab, A., Liu, D., Zhang, Y., Huang, B., & Lu, J. (2017). The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell Death & Differentiation, 24(1), 59–71.
doi: 10.1038/cdd.2016.95
Mou, E., & Wang, H. (2019). LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702. Bioscience Reports, 39(9), BSR20190489.
doi: 10.1042/BSR20190489
Kong, X., Duan, Y., Sang, Y., Li, Y., Zhang, H., Liang, Y., Liu, Y., Zhang, N., & Yang, Q. (2019). LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215. Journal of Cellular Physiology, 234(6), 9105–9117.
doi: 10.1002/jcp.27587
Zhou, T., Lin, K., Nie, J., Pan, B., He, B., Pan, Y., Sun, H., Xu, T., & Wang, S. (2021). LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p. Pathology-Research and Practice, 217, 153268.
doi: 10.1016/j.prp.2020.153268
He, W., Li, D., & Zhang, X. (2022). LncRNA HOTAIR promotes the proliferation and invasion/metastasis of breast cancer cells by targeting the miR-130a-3p/Suv39H1 axis. Biochemistry and Biophysics Reports, 30, 101279.
doi: 10.1016/j.bbrep.2022.101279
Han, C., Fu, Y., Zeng, N., Yin, J., & Li, Q. (2020). LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Aging (Albany NY), 12(4), 3594–3616.
doi: 10.18632/aging.102832
Yue, X., Wu, W. Y., Dong, M., & Guo, M. (2021). LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570–3p. Biomedical Journal, 44(6), S296–S304.
doi: 10.1016/j.bj.2020.11.002
Zhou, J.-L., Zou, L., & Zhu T., (2020). Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT. European Review for Medical & Pharmacological Sciences, 24(6).
Fan, H., Yuan, J., Li, X., Ma, Y., Wang, X., Xu, B., & Li, X. (2020). LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression. Biomedicine & Pharmacotherapy, 125, 109987.
doi: 10.1016/j.biopha.2020.109987
Yuan, C., Luo, X., Duan, S., & Guo, L. (2020). Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR‐7. FEBS Open Bio, 10(7), 1230–1237.
doi: 10.1002/2211-5463.12842
Liu, W., Zhou, X., Li, Y., Jiang, H., & Chen, A. (2021). Long non-coding RNA norad inhibits breast cancer cell proliferation and metastasis by regulating mir-155-5p/socs1 axis. Journal of Breast Cancer, 24(3), 330–343.
doi: 10.4048/jbc.2021.24.e32
Li, X., Hou, L., Yin, L., & Zhao, S. (2020). LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer. Journal of Biosciences, 45(1), 45.
doi: 10.1007/s12038-020-9999-7
Wang, Y., & Cai, X. (2020). Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7. Cancer Biomarkers, 27(1), 85–94.
doi: 10.3233/CBM-190530
Jin, Y., Xu, L., Zhao, B., Bao, W., Ye, Y., Tong, Y., Sun, Q., & Liu, J. (2022). Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells. Cell Cycle, 21(9), 908–920.
doi: 10.1080/15384101.2022.2034254
Hu, J., Huang, H., Xi, Z., Ma, S., Ming, J., Dong, F., Guo, H., Zhang, H., Zhao, E., Yao, G., Yang, L., Zhang, F., Zheng, W., Chen, H., Huang, T., & Li, L. (2022). LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis. Cell Death & Disease, 13(9), 800.
doi: 10.1038/s41419-022-05189-7
Li, Q., Mo, W., Ding, Y., & Ding, X. (2021). Study of lncRNA TPA in promoting invasion and metastasis of breast cancer mediated by TGF-β signaling pathway. Frontiers in Cell and Developmental Biology, 9, 688751.
doi: 10.3389/fcell.2021.688751
Shi, S.-J., Wang, L. J., Yu, B., Li, Y. H., Jin, Y., & Bai, X. Z. (2015). LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget, 6(13), 11652–63.
doi: 10.18632/oncotarget.3457
Yang, Y.-X., Wei, L., Zhang, Y. J., Hayano, T., Piñeiro Pereda, M., Nakaoka, H., Li, Q., Barragán Mallofret, I., Lu, Y. Z., Tamagnone, L., Inoue, I., Li, X., Luo, J. Y., Zheng, K., & You, H. (2018). Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis. Clinical & Experimental Metastasis, 35, 109–121.
doi: 10.1007/s10585-018-9901-2
Zong, S., Dai, W., Guo, X., & Wang, K. (2021). LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis. Aging (Albany NY), 13(19), 23169–23181.
doi: 10.18632/aging.203609
Kong, X., Li, J., Li, Y., Duan, W., Qi, Q., Wang, T., Yang, Q., Du, L., Mao, H., & Wang, C. (2021). A novel long non-coding RNA AC073352. 1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. Cell Death & Disease, 12(7), 670.
doi: 10.1038/s41419-021-03943-x
Xu, Y., Ren, W., Li, Q., Duan, C., Lin, X., Bi, Z., You, K., Hu, Q., Xie, N., Yu, Y., Xu, X., Hu, H., & Yao, H. (2022). LncRNA Uc003xsl. 1-Mediated activation of the NFκB/IL8 axis promotes progression of triple-negative breast cancer. Cancer Research, 82(4), 556–570.
doi: 10.1158/0008-5472.CAN-21-1446
Li, Y., Ma, H. Y., Hu, X. W., Qu, Y. Y., Wen, X., Zhang, Y., & Xu, Q. Y. (2020). LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway. Cancer Cell International, 20, 1–14.
Wang, S., Liang, K., Hu, Q., Li, P., Song, J., Yang, Y., Yao, J., Mangala, L. S., Li, C., Yang, W., Park, P. K., Hawke, D. H., Zhou, J., Zhou, Y., Xia, W., Hung, M. C., Marks, J. R., Gallick, G. E., Lopez-Berestein, G., Flores, E. R., Sood, A. K., Huang, S., Yu, D., Yang, L., & Lin, C. (2017). JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. The Journal of Clinical Investigation, 127(12), 4498–4515.
doi: 10.1172/JCI91553
Zhang, J., Du, C., Zhang, L., Wang, Y., Zhang, Y., & Li, J. (2022). LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex. Cell Cycle, 21(10), 1034–1047.
doi: 10.1080/15384101.2022.2040283
Xiu, B., Chi, Y., Liu, L., Chi, W., Zhang, Q., Chen, J., Guo, R., Si, J., Li, L., Xue, J., Shao, Z. M., Wu, Z. H., Huang, S., & Wu, J. (2019). LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Molecular Cancer, 18, 1–20.
doi: 10.1186/s12943-019-1115-y
Qiao, Y., Jin, T., Guan, S., Cheng, S., Wen, S., Zeng, H., Zhao, M., Yang, L., Wan, X., Qiu, Y., Li, Q., Liu, M., & Hou, Y. (2021). Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1. Oncogene, 40(24), 4198–4213.
doi: 10.1038/s41388-021-01845-y
Liu, M., Gou, L., Xia, J., Wan, Q., Jiang, Y., Sun, S., Tang, M., He, T., & Zhang, Y. (2018). LncRNA ITGB2-AS1 could promote the migration and invasion of breast cancer cells through up-regulating ITGB2. International Journal of Molecular Sciences, 19(7), 1866.
doi: 10.3390/ijms19071866
Eroğlu Güneş, C., Güçlü, E., Vural, H., & Kurar, E. (2021). Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells. Gene, 805, 145904.
doi: 10.1016/j.gene.2021.145904
Jia, X., Shi, L., Wang, X., Luo, L., Ling, L., Yin, J., Song, Y., Zhang, Z., Qiu, N., Liu, H., Deng, M., He, Z., Li, H., & Zheng, G. (2019). KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation. Cell Death & Disease, 10(5), 373.
doi: 10.1038/s41419-019-1566-5
Zhou, W., Ye, X. L., Xu, J., Cao, M. G., Fang, Z. Y., Li, L. Y., Guan, G. H., Liu, Q., Qian, Y. H., & Xie, D. (2017). The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Science Signaling, 10(483), eaak9557.
doi: 10.1126/scisignal.aak9557
Jin, Y., Zhang, M., Duan, R., Yang, J., Yang, Y., Wang, J., Jiang, C., Yao, B., Li, L., Yuan, H., Zha, X., & Ma, C. (2020). Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis. Cell Death Discovery, 6(1), 103.
doi: 10.1038/s41420-020-00334-7
Zhao, L., Zhou, Y., Zhao, Y., Li, Q., Zhou, J., & Mao, Y. (2020). Long non-coding RNA TUSC8 inhibits breast cancer growth and metastasis via miR-190b-5p/MYLIP axis. Aging (Albany NY), 12(3), 2974–2991.
doi: 10.18632/aging.102791
Niu, Y., Bao, L., Chen, Y., Wang, C., Luo, M., Zhang, B., Zhou, M., Wang, J. E., Fang, Y. V., Kumar, A., Xing, C., Wang, Y., & Luo, W. (2020). HIF2-induced long noncoding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis. Cancer Research, 80(5), 964–975.
doi: 10.1158/0008-5472.CAN-19-1532
Dong, F., Ruan, S., Wang, J., Xia, Y., Le, K., Xiao, X., Hu, T., & Wang, Q. (2020). M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2. Cell Death & Disease, 11(9), 728.
doi: 10.1038/s41419-020-02926-8
Zhang, Z., Lu, Y. X., Liu, F., Sang, L., Shi, C., Xie, S., Bian, W., Yang, J. C., Yang, Z., Qu, L., Chen, S. Y., Li, J., Yang, L., Yan, Q., Wang, W., Fu, P., Shao, J., Li, X., & Lin, A. (2023). lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1. Proceedings of the National Academy of Sciences USA, 120(8), e2206694120.
doi: 10.1073/pnas.2206694120
Zheng, S., et al. (2020). Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer. Journal of Hematology & Oncology, 13, 1–15.
Fang, K., Hu, C., Zhang, X., Hou, Y., Gao, D., Guo, Z., & Li, L. (2020). LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway. Carcinogenesis, 41(9), 1273–1281.
doi: 10.1093/carcin/bgz197
Zeng, H., Hou, Y., Zhou, X., Lang, L., Luo, H., Sun, Y., Wan, X., Yuan, T., Wang, R., Liu, Y., Tang, R., Cheng, S., Xu, M., & Liu, M. (2022). Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer. Theranostics, 12(17), 7351–7370.
doi: 10.7150/thno.74753
Zhao, Y.-F., Li, L., Li, H. J., Yang, F. R., Liu, Z. K., Hu, X. W., & Wang, Q. (2020). LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6. European Review for Medical & Pharmacological Sciences, 24(21), 11139–11147.
Nyati, K. K., Hashimoto, S., Singh, S. K., Tekguc, M., Metwally, H., Liu, Y. C., Okuzaki, D., Gemechu, Y., Kang, S., & Kishimoto, T. (2021). The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway. Cancer Letters, 520, 295–306.
doi: 10.1016/j.canlet.2021.08.004
Li, Z., Dong, M., Fan, D., Hou, P., Li, H., Liu, L., Lin, C., Liu, J., Su, L., Wu, L., Li, X., Huang, B., Lu, J., & Zhang, Y. (2017). LncRNA ANCR down-regulation promotes TGF-β-induced EMT and metastasis in breast cancer. Oncotarget, 8(40), 67329–67343.
doi: 10.18632/oncotarget.18622
Chen, D.-Q., Zheng, X. D., Cao, Y., He, X. D., Nian, W. Q., Zeng, X. H., & Liu, X. Y. (2017). Long non-coding RNA LINC00628 suppresses the growth and metastasis and promotes cell apoptosis in breast cancer. European Review for Medical & Pharmacological Sciences, 21(2), 275–283.
Zhang, Y., Zhu, M., Sun, Y., Li, W., Wang, Y., & Yu, W. (2019). Upregulation of lncRNA CASC2 suppresses cell proliferation and metastasis of breast cancer via inactivation of the TGF-β signaling pathway. Oncology Research, 27(3), 379–387.
doi: 10.3727/096504018X15199531937158
Wu, W., Chen, F., Cui, X., Yang, L., Chen, J., Zhao, J., Huang, D., Liu, J., Yang, L., Zeng, J., Zeng, Z., Pan, Y., Su, F., Cai, J., Ying, Z., Zhao, Q., Song, E., & Su, S. (2018). LncRNA NKILA suppresses TGF‐β‐induced epithelial–mesenchymal transition by blocking NF‐κB signaling in breast cancer. International Journal of Cancer, 143(9), 2213–2224.
doi: 10.1002/ijc.31605
Yang, F., & Lv, S. (2022). LncRNA EPB41L4A-AS1 regulates cell proliferation, apoptosis and metastasis in breast cancer. Annals of Clinical & Laboratory Science, 52(1), 3–11.
Chang, K.-C., Diermeier, S. D., Yu, A. T., Brine, L. D., Russo, S., Bhatia, S., Alsudani, H., Kostroff, K., Bhuiya, T., Brogi, E., Pappin, D. J., Bennett, C. F., Rigo, F., & Spector, D. L. (2020). MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression. Nature Communications, 11(1), 6438.
doi: 10.1038/s41467-020-20207-y
Guo, G., Dai, S., & Chen, Q. (2020). Long noncoding RNA LINC00261 reduces proliferation and migration of breast cancer cells via the NME1-EMT pathway. Cancer Management and Research, 12, 3081–3089.
doi: 10.2147/CMAR.S237197
Sharma, U., Barwal, T. S., Khandelwal, A., Malhotra, A., Rana, M. K., Singh Rana, A. P., Imyanitov, E. N., Vasquez, K. M., & Jain, A. (2021). LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Biochimie, 182, 99–107.
doi: 10.1016/j.biochi.2020.12.026